☆ 4.8 Article

High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection

NATURE COMMUNICATIONS (2022)

Related references

Note: Only part of the references are listed.

Article Immunology

Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection

Alexander C. Dowell et al.

Summary: Children exhibit stronger and more sustained immune responses to SARS-CoV-2 infection, with higher levels of antibodies and T cell responses compared to adults, and the ability to neutralize various viral variants. These findings suggest that children may have a more robust immune system against the virus, potentially providing insight into the milder clinical presentation of SARS-CoV-2 in most children.

NATURE IMMUNOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Robust and durable serological response following pediatric SARS-CoV-2 infection

Hanna Renk et al.

Summary: This study compares the humoral immune response in children and adults following SARS-CoV-2 infection and finds that children are more likely to have asymptomatic infections and higher levels of specific antibodies that persist for a longer time. Symptomatic and asymptomatic infections induce similar humoral responses across all age groups.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children

J. Loske et al.

Summary: Children exhibit higher basal expression of relevant pattern recognition receptors in airway immune cells, resulting in stronger early innate antiviral responses to SARS-CoV-2 infection compared to adults. Unique immune cell subpopulations, including cytotoxic T cells and memory CD8+ T cells, predominantly occur in children.

NATURE BIOTECHNOLOGY (2022)

Add to Collection

Article Immunology

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde et al.

Summary: SARS-CoV-2-specific T cell epitopes were identified in convalescent and unexposed individuals, showing cross-reactivity with common cold coronaviruses. The diversity of SARS-CoV-2 T cell responses may be associated with mild symptoms of COVID-19.

NATURE IMMUNOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

Lauren B. Rodda et al.

Summary: The study found that individuals recovered from mild COVID-19 develop sustained SARS-CoV-2-specific immunological memory for at least 3 months, including immunoglobulin antibodies, neutralizing plasma, and memory B and T cells. These memory lymphocytes exhibit potent antiviral function, aiding in immune defense.

CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

COVID-19-neutralizing antibodies predict disease severity and survival

Wilfredo F. Garcia-Beltran et al.

Summary: Severe cases of COVID-19 show increased inflammatory markers, lymphopenia, pro-inflammatory cytokines, and high antibody levels. High neutralization potency is a predictor of survival. Patient sera can neutralize different strains, indicating cross-protection from reinfection.

CELL (2021)

Add to Collection

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Add to Collection

Article Pediatrics

Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany

Burkhard Toenshoff et al.

Summary: A study conducted in southwest Germany showed that the rate of SARS-CoV-2 infections was low among children aged 1 to 10, suggesting that they are unlikely to have significantly contributed to the pandemic. Large-scale testing provides a basis for informed political decision-making during a pandemic.

JAMA PEDIATRICS (2021)

Add to Collection

Article Immunology

COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses

Agnes Bonifacius et al.

Summary: Research showed that active COVID-19 patients had high levels of anti-SARS-CoV-2 nucleocapsid and spike IgG, but overall reduced antiviral T cell responses due to inflammatory environment, expression of inhibitory molecules, and effector caspase activity in T cells.

IMMUNITY (2021)

Add to Collection

Article Multidisciplinary Sciences

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination

Alice Cho et al.

Summary: Infection with SARS-CoV-2 leads to evolving B cell responses over at least a year, while vaccination with mRNA vaccines results in high plasma neutralizing activity against various variants. Memory B cells from vaccinated individuals show increased neutralizing activity between prime and boost, but do not exhibit further expansion in potency or breadth.

NATURE (2021)

Add to Collection

Article Medicine, Research & Experimental

SARS-CoV-2 specific CD8+ T cell responses in convalescent COVID-19 individuals

Hassen Kared et al.

Summary: Characterization of T cell responses in convalescent individuals from SARS-CoV-2 infection revealed unique phenotypes and a coordinated immune response, with specific CD8(+) T cell responses directed against various epitopes from the virus proteome. The differentiation of T cells into stem cell and transitional memory subsets may be crucial for developing lasting protection against the virus.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Immunology

Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection

Margherita Rosati et al.

Summary: A study revealed that convalescent patients maintain robust antibody responses to SARS-CoV-2 for over a year after infection, providing long-lasting protection. The data showed that antibodies from convalescent patients persist over 14 months, continue to maintain cross-reactivity to current variants of concern, and exhibit strong functional properties.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors

Bernd Jahrsdoerfer et al.

Summary: The study revealed that SARS-CoV-2 neutralization titers remain stable or even increase for at least seven months after diagnosis, showing a positive correlation with age, symptom number, and specific antigen presence. Platform validation indicated the wild-type virus and surrogate neutralization tests had the highest assay performances, but the selection of cutoff titers significantly affected the evaluation of neutralization potency.

JOURNAL OF IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Persisting Salivary IgG against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys

Hassan Alkharaan et al.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Pediatrics

Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2

Erika Molteni et al.

Summary: Most school-aged children in the UK with SARS-CoV-2 infection are asymptomatic or experience mild illness, with longer duration and higher symptom burden observed in older children. Persistence of illness is more common in older children, but symptom burden does not increase over time and most recover within 56 days. Children who test negative for SARS-CoV-2 may also experience prolonged illness with higher symptom burden.

LANCET CHILD & ADOLESCENT HEALTH (2021)

Add to Collection

Article Cell Biology

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Tatjana Bilich et al.

Summary: The study found that antibody responses in COVID-19 convalescent individuals decreased or remained stable within 6 months, while T cell responses showed a robust increase. T cell responses included key epitopes that mediate long-term SARS-CoV-2 immunity.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Immunology

Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations

Frauke Muecksch et al.

Summary: This study examined the development of antibodies following infection with the coronavirus, finding that evolved antibodies had increased affinity and neutralization potency, altered mutational pathways for viral resistance, and restricted neutralization escape options. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying populations of the virus and other pandemic threat coronaviruses.

IMMUNITY (2021)

Add to Collection

Article Immunology

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants

Saya Moriyama et al.

Summary: Antibody titers against SARS-CoV-2 decrease over time, but the neutralizing potency against the original virus and variants actually improves with time. Late convalescent antibodies show increased neutralization potency against variants, suggesting that antibody response maturation enhances cross-neutralizing ability against circulating variants. This indicates that declining antibody titers may not necessarily mean declining protection.

IMMUNITY (2021)

Add to Collection

Article Multidisciplinary Sciences

Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine

Valerie Oberhardt et al.

Summary: After vaccination, CD8(+) T cells become important effector cells in providing early protection, being effectively mobilized one week after primary vaccination and maintaining stability after booster vaccination. Compared with natural infection, vaccine-induced CD8(+) T cells exhibit similar functional capacities but with a different subset distribution.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

Zijun Wang et al.

Summary: Despite challenges posed by COVID-19 variants, convalescent individuals receiving mRNA vaccines exhibit robust and long-lasting immune responses against circulating SARS-CoV-2 variants, providing hope for effective control of the pandemic.

NATURE (2021)

Add to Collection

Article Pediatrics

Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers

Francesco Bonfante et al.

Summary: In a family cluster, children with mild or asymptomatic infections of severe acute respiratory syndrome coronavirus 2 developed higher levels of neutralizing antibodies compared to older siblings and adults.

PEDIATRICS (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection

Carolyn A. Cohen et al.

Summary: This study shows that infected children have lower CD4(+) and CD8(+) T cell responses to SARS-CoV-2 proteins compared to infected adults. Children also have reduced CD4(+) T cell effector memory but comparable T cell polyfunctionality.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery

Chengqian Feng et al.

Summary: The study found that SARS-CoV-2 specific immune response can persist to some extent up to 1 year after recovery from COVID-19, with serum neutralizing capacity decreasing but remaining stable. Viral-specific cellular immune protection persists between 6 months and 12 months after recovery.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Immunology

Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Households with Children, Southwest Germany, May-August 2020

Maximilian Stich et al.

Summary: A large-scale study conducted in southwest Germany found that the secondary attack rate of SARS-CoV-2 was significantly higher in exposed adults compared to children in households. Additionally, the transmission rate was higher when the index case-patient was over 60 years old. Risk factors for infectiousness of the index case-patient included SARS-CoV-2 seropositivity, fever, and cough.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Article Cell Biology

Young infants exhibit robust functional antibody responses and restrained IFN-γ production to SARS-CoV-2

Anu Goenka et al.

Summary: The study suggests that severe cases of COVID-19 in infants are rare, and infants show distinct immune responses compared to adults, which may help protect them from severe disease.

CELL REPORTS MEDICINE (2021)

Add to Collection

Article Cell Biology

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

Sai Priya Anand et al.

Summary: Recent research on convalescent individuals of COVID-19 has shown a decline in antibody levels in plasma, while specific memory B cells remain present. IgM antibodies against Spike and RBD decay rapidly, whereas IgG decline is less significant. Understanding these immune memory responses is crucial for secondary infection prevention and vaccine efficacy.

CELL REPORTS MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells

Isabel Schulien et al.

Summary: The study found that SARS-CoV-2 infection induces and forms functionally competent memory CD8(+) T cell responses, which can persist in some SARS-CoV-2 convalescent individuals. Even in the absence of virus-specific antibodies, these virus epitope-specific CD8(+) T cell responses are induced following infection.

NATURE MEDICINE (2021)

Add to Collection

Article Immunology

Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum

Stuart P. Weisberg et al.

Summary: This study found distinct antibody responses in children and adults after SARS-CoV-2 infection. Adult COVID-19 cohorts showed a broader range of antibody responses, while children predominantly generated antibodies specific for the S protein and had reduced neutralizing activity compared to adults.

NATURE IMMUNOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Alba Grifoni et al.

CELL (2020)

Add to Collection

Review Immunology

T follicular helper cells in germinal center B cell selection and lymphomagenesis

Michelle A. Mintz et al.

IMMUNOLOGICAL REVIEWS (2020)

Add to Collection

Letter Immunology

Immune response in children with COVID-19 is characterized by lower levels of T-cell activation than infected adults

Daniele Moratto et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Julian Braun et al.

NATURE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Age-dependent effects in the transmission and control of COVID-19 epidemics

Nicholas G. Davies et al.

NATURE MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Christopher O. Barnes et al.

NATURE (2020)

Add to Collection

Article Immunology

Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Yanchun Peng et al.

NATURE IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence

Gemma E. Hartley et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients

Baweleta Isho et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Review Immunology

Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination

Anna-Karin E. Palm et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Review Immunology

Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations

Ignacio Sanz et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Immunology

T Follicular Helper Cell-Germinal Center B Cell Interaction Strength Regulates Entry into Plasma Cell or Recycling Germinal Center Cell Fate

Wataru Ise et al.

IMMUNITY (2018)

Add to Collection

Article Allergy

Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood

Elena Blanco et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Add to Collection

Article Immunology

Differences Between Pediatric and Adult T Cell Responses to In Vitro Staphylococcal Enterotoxin B Stimulation

Mark E. Rudolph et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Review Immunology

The regulation of gut mucosal IgA B-cell responses: recent developments

N. Y. Lycke et al.

MUCOSAL IMMUNOLOGY (2017)

Add to Collection

Article Biochemical Research Methods

Complex heatmaps reveal patterns and correlations in multidimensional genomic data

Zuguang Gu et al.

BIOINFORMATICS (2016)

Add to Collection

Article Immunology

Kinetics of antibody and memory B cell responses after MMR immunization in children and young adults

Maria Kakoulidou et al.

VACCINE (2013)

Add to Collection

Article Immunology

Age-matched Reference Values for B-lymphocyte Subpopulations and CVID Classifications in Children

E. J. H. Schatorje et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)

Add to Collection

Article Allergy

The germinal center reaction

Dominique Gatto et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

Add to Collection

Article Biochemical Research Methods

Rapid identification and sorting of viable virus-reactive CD4+ and CD8+ T cells based on antigen-triggered CD137 expression

Thomas C. Wehler et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2008)

Add to Collection

Review Immunology

Antibodies and B cell memory in viral immunity

Thomas Doerner et al.

IMMUNITY (2007)

Add to Collection

Article Allergy

Lymphocyte subsets in healthy children from birth through 18 years of age: The pediatric AIDS clinical trials group P1009 study

WT Shearer et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)

Add to Collection

Article Multidisciplinary Sciences

Maintenance of serological memory by polyclonal activation of human memory B cells

NL Bernasconi et al.

SCIENCE (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.